** Shares of telehealth firm Doximity DOCS.N rise 24.4% to $72.50 premarket
** On Thursday, co forecast fiscal 2025 rev. to be between $564.6 mln and $565.6 mln, up from its previous range of $535 mln to $540 mln; analysts estimate 2025 rev. to be $554.3 mln - LSEG-compiled data
** Co forecasts Q4 rev. to be between $132.5 mln and $133.5 mln, above analysts' est of $129.2 mln
** Co reported Q3 adj. profit of 45 cents/shr vs analysts' est. of 34 cents/shr
** Co posted Q3 revenue of $168.6 mln vs estimates of $152.8 mln
** At least six brokerages raised PT on DOCS post results
** DOCS gained ~87% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。